Generic Name: brinzolamide

Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%
Status: Completed Condition: Open-Angle Glaucoma; Ocular Hypertension

Three Month Efficacy/Safety Study With a 3 Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%
Status: Completed Condition: Open Angle Glaucoma; Ocular Hypertension

Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)
Status: Terminated Condition: Intraocular Pressure

Efficacy and Safety of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination BID vs. Brinzolamide 1% BID Plus Brimonidine 0.2% BID
Status: Completed Condition: Open-angle Glaucoma or Ocular Hypertension

A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%
Status: Completed Condition: Open-angle Glaucoma; Ocular Hypertension

Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH
Status: Not yet recruiting Condition: Open Angle Glaucoma; Ocular Hypertension

Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Completed Condition: Open-angle Glaucoma; Ocular Hypertension

Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs
Status: Completed Condition: Primary Open Angle Glaucoma; Ocular Hypertension

Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-angle Glaucoma or Ocular Hypertension
Status: Completed Condition: Open-angle Glaucoma; Ocular Hypertension

Topical Brinzolamide Ophthalmic Suspension Versus Placebo in the Treatment of Infantile Nystagmus Syndrome
Status: Recruiting Condition: Infantile Nystagmus Syndrome